Chapter 10: Mechanisms of Infectious Disease – Pathogens & Immunity

The field of infectious disease is defined by the classic triad model, which analyzes how an infectious agent, a susceptible host, and environmental factors interact to promote illness. This chapter introduces the diverse range of pathogenic agents—including misfolded protein prions, obligate intracellular viruses, prokaryotic bacteria, and eukaryotic organisms like fungi and various parasites (protozoa, helminths, and arthropods)—and details how their relationship with the human host progresses from benign commensalism or mutualism to damaging parasitic infection. Understanding the mechanisms of infection requires examining how pathogens enter the body, transmitted via modes such as penetration through barriers, direct contact, ingestion, or inhalation, originating from sources like exogenous environments, inanimate fomites, or zoonotic vectors. A pathogen’s power to cause severe illness, or its virulence, is dependent on specialized factors such as secreted exotoxins and cell wall endotoxins, specialized adhesion structures, evasive defenses like capsules that resist phagocytosis, and invasive enzymes that break down host tissues. The typical course of an infection unfolds across several identifiable stages: incubation, prodromal, acute, convalescent, and ultimate resolution. Accurate diagnosis integrates clinical signs with laboratory methods, utilizing traditional culture techniques, serology to track antibody titers (IgM and IgG), and modern genomic detection tools like polymerase chain reaction (PCR) for rapid identification of DNA or RNA sequences. Treatment protocols are customized based on the pathogen type and may include medical therapies such as targeted antimicrobial agents (antibiotics, antivirals, antifungals), immune system support via immunotherapy, and surgical interventions to manage localized infections like abscesses. Finally, the chapter highlights global threats, addressing the risks associated with categorized bioterrorism agents and the ongoing challenge of emerging global infectious diseases amplified by international travel.